| Literature DB >> 33050122 |
Carolina Rodrigues Mendonça1, Matias Noll1,2, Maria Clara Rezende Castro1, Erika Aparecida Silveira1.
Abstract
Food consumption has significant positive effects on an individual's health status, including the reduction of symptoms associated with musculoskeletal pain. However, specific food groups indicated for the treatment of pain are not yet determined. Hence, this review aimed to analyze the effects of nutritional interventions with specific diets, oils and/or fatty acids, and foodstuffs in natura in the reduction of musculoskeletal pain. An integrative review was conducted in the following databases: Embase, PubMed, LILACS, and Google Scholar. Clinical trials written in English, Spanish, and Portuguese and published between 2000 and March 2020 were included in this review. Seventeen studies were included. Among these, a reduction of musculoskeletal pain with different types of nutritional interventions, such as vegan and Mediterranean diets and the consumption of blueberry, strawberry, passion fruit peel extract, argan oil, fish oil (omega-3), olive oil, and undenatured type II collagen and vitamin D gel capsules, was observed in 14 studies. Eight studies evaluated the profiles of several inflammatory markers, and of these, decreased interleukin (IL)-6, IL-1β, and tumor necrosis factor-α levels were observed in two studies. This review suggests that different nutritional interventions with specific diets, oils and/or fatty acids, and foodstuffs in natura reduce musculoskeletal pain, specifically in adults with osteoarthritis. Besides pain improvement, nutritional interventions, including the consumption of strawberry and vitamin D gel capsules, decrease the levels of several inflammatory markers.Entities:
Keywords: diet therapy; fatty acids; fruit; inflammatory markers; muscle; obesity; skeletal
Mesh:
Substances:
Year: 2020 PMID: 33050122 PMCID: PMC7601187 DOI: 10.3390/nu12103075
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Study selection flowchart.
Nutritional interventions with specific diets on musculoskeletal pain, other musculoskeletal manifestations, and inflammatory markers.
| Authors/Year/ | Population | Type of Study | Follow-Up Period | Intervention | Outcomes Assessed | Pain Assessment Instrument Used | Main Results | Reduction of Pain |
|---|---|---|---|---|---|---|---|---|
| Slim et al. (2017) [ | Randomized clinical trial | 24 weeks | Group 1: Gluten-free diet ( | Pain | Brief Pain Inventory-Short Form (BPI-SF) | There was a slight reduction in pain that did not differ significantly between the two study groups ( | No | |
| McKellar et al. (2007) [ | Pilot study of dietary intervention | 6 weeks | Group 1: Mediterranean diet | Pain | Global Pain Scale | Pain score was lower in group 1 ( | Yes | |
| Sköldstam; Hagfors; Johansson (2003) [ | Randomized, parallel study | 13 weeks | Group1: Mediterranean diet ( | Pain | VAS | In group 1 there was an improvement in joint swelling ( | Yes | |
| Kaartinen et al. (2000) [ | N = 28 with fibromyalgia | Non-randomized clinical trial | 13 weeks | Group 1: Vegan diet “living food”: uncooked foods, fruits, vegetables, mushrooms, nuts, seeds, legumes, and cereals ( | Pain | VAS | There was a reduction in pain observed on the visual analogue pain scale ( | Yes |
IL-6, interleukin 6; CRP, C-reactive protein; VAS, Visual Analog Scale; a Daily intake of 1829 kcal, protein intake 71 g (16%-E), carbohydrate intake 276 g (53%-E), fat intake 63 g (31%-E), and no cholesterol.
Nutritional interventions with fruits on the outcomes of musculoskeletal pain, other musculoskeletal manifestations, and inflammatory markers.
| Authors/Year/ | Population | Type of Study | Follow-Up Period | Intervention | Outcomes Assessed | Pain Assessment Instrument Used | Main Results | Reduction of Pain |
|---|---|---|---|---|---|---|---|---|
| Du et al. (2019) [ | Randomized, double-blind | 17 weeks | Group 1: 40-g freeze-dried blueberry powder, in 20-g packs for daily consumption. Consumed twice a day ( | Pain | WOMAC questionnaire | There was a significant reduction of pain in the treatment group with blueberry ( | Yes | |
| Schell et al. (2017) [ | Randomized, double-blind | 26 weeks | Group 1: 50 g of freeze-dried strawberry beverage consumed twice a day ( | Pain | ICOAP Pain Questionnaire | Significant reduction of pain (all | Yes | |
| Ghoochani et al. (2016) [ | Randomized clinical trial | 6 weeks | Group 1: pomegranate juice intervention ( | Pain | WOMAC questionnaire | Group 1 patients reported a significant reduction in stiffness ( | No | |
| Farid et al. (2010) [ | N = 33 adults with osteoarthritis of the knee | Randomized, double-blind, placebo-controlled study, with parallel group design | 8 weeks | Group 1: Passion fruit peel extract ( | Pain | WOMAC questionnaire | There was a significant reduction in physical function after 30 days and pain after 60 days in group 1 ( | Yes |
IL, interleukin; MCP-1, monocyte chemoattractant protein-1; MMP-3, matrix metalloproteinase-3; MMP-8, matrix metalloproteinase-8; MMP-13, matrix metalloproteinase-13; TNF, tumor necrosis factor; CRP, C-reactive protein; WOMAC, Western Ontario and McMaster Universities Arthritis Index; a, Not indicated; ICOAP, Intermittent and Constant Osteoarthritis Pain.
Nutritional interventions with the use of olive oil, omega-3, and other oils on musculoskeletal pain, other musculoskeletal manifestations, and inflammatory markers.
| Authors/Year/ | Population | Type of Study | Follow-up Period | Intervention | Outcomes Assessed | Pain Assessment Instrument | Main Results | Reduction of Pain |
|---|---|---|---|---|---|---|---|---|
| Essouiri J et al. (2017) [ | Randomized clinical trial | 8 weeks | Group 1: argan oil to be consumed each morning (30 mL per day) ( | Pain | VAS and WOMAC questionnaire | More significant reductions in pain were found by the VAS ( | Yes | |
| Hill et al. (2016) [ | Randomized clinical trial | 104 weeks | Group 1. High dose of fish oil (omega-3 fatty acids 15 mL/day) ( | Pain | WOMAC questionnaire | There was a greater reduction in pain scores at 2 years of follow-up in group 2 compared with group 1 | Yes | |
| Peanpadungrat (2015) [ | Randomized clinical trial | 12 weeks | - Group 1. Without fish oil supplement ( | Pain | WOMAC questionnaire | There was a significant reduction in pain and stiffness in groups 1 and 2 ( | Yes | |
| Bitler et al. (2007) [ | Double-blind, placebo-controlled randomized clinical trial | 8 weeks | Group 1: Olive oil capsules rich in polyphenols. ( | Pain | VAS | There was a significant reduction of pain in the treatment group ( | Yes | |
| Berbert et al. (2005) [ | Randomized clinical trial | 12 and 24 weeks | Group 1. Placebo (soybean oil) ( | Pain | VAS | A more statistically significant reduction ( | Yes |
IL, interleukin; CRP, C-reactive protein; WOMAC, Western Ontario and McMaster Universities Arthritis Index; VAS, Visual Analog Scale.
Nutritional interventions with other food supplements on musculoskeletal pain, other musculoskeletal manifestations, and inflammatory markers.
| Authors/Year/ | Population | Type of Study | Follow-Up Period | Intervention | Outcomes Assessed | Pain Assessment Instrument | Main Results | Reduction of Pain |
|---|---|---|---|---|---|---|---|---|
| Lugo et al. (2016) [ | Randomized, double-blind, placebo-controlled clinical study | 25 weeks | Group 1: undenatured type II collagen (40 mg) ( | Pain | WOMAC questionnaire | Significant reduction for all three WOMAC subscales in group 1: pain ( | Yes | |
| Solà et al. (2015) [ | Randomized, double-blind, placebo-controlled parallel study | 12 weeks | Group 1. skimmed yogurt (125 mL d (1)) supplemented with 80 mg d (−1) of the crest of the rooster “roostercombextract (RCE) rich in hyaluronicacid” | Pain | VAS | There were no significant differences between the groups for the inflammatory markers | No | |
| Gendelman et al. (2015) [ | Randomized, double-blind and controlled study | 13 weeks | Group 1. 4000 IU of vitamin D3 orally (4 gel capsules of 1000 units) ( | Pain | VAS | There were no statistically significant differences between the intervention and control groups in relation to pain (p = not reported) | Yes | |
| Schreuder et al. (2012) [ | Randomized controlled study | 6 weeks | Group 1. Vitamin D (150,000 IU of vitamin D (3) orally) ( | Pain | VAS | Group 1 had significantly lower pain reduction than the placebo group ( | Yes |
IL, interleukin; MMP-3, matrix metalloproteinase-3; TNF, tumor necrosis factor; CRP, C-reactive protein; WOMAC, Western Ontario and McMaster Universities Arthritis Index; VAS, Visual Analog Scale.
Figure 2Assessment of risk of bias. (A) Summary of risk of bias for each trial (plus sign denotes low risk of bias; minus sign, high risk of bias; question mark, unclear risk of bias). (B) Risk of bias graph with each risk of bias item presented as percentages across all included studies.